GoHealthcare Practice Solutions | MSK Specialty Procedure Library™

Thoracic Medial Branch Radiofrequency Ablation

Thermal Facet Joint Denervation (Medial Branch Neurotomy) of the Thoracic Spine

CPT 64633CPT +64634Pain ManagementSpineASC

Coverage fault line: Carelon’s current 2026 guideline generally excludes thoracic facet RFA except at C7-T1 and T12-L1, while Medicare and eviCore may cover selected thoracic cases. Verify the member-specific pathway before diagnostic blocks.

Publication Standard

Publication and Use Information

This GoHealthcare MSK Specialty Procedure Library™ guide is designed for physicians, advanced practice professionals, clinical teams, prior authorization specialists, utilization-management professionals, coders, billers, revenue-cycle leaders, practice administrators, ambulatory surgery centers, and healthcare executives.

It provides clinical, operational, coding, documentation, prior authorization, reimbursement, denial-prevention, and compliance guidance for thoracic medial branch radiofrequency ablation. It does not replace independent clinical judgment, official CPT and ICD-10-CM publications, the member’s benefit plan, the active Medicare Administrative Contractor policy, current commercial payer criteria, or applicable law.

Coverage varies materially by payer and delegated reviewer. Of particular importance, some policies cover appropriately selected thoracic RFA, while Carelon’s current 2026 interventional pain guideline excludes thoracic facet injection, medial branch block, and RFA except at C7-T1 and T12-L1. The live plan-specific policy must be verified before treatment or claim submission.

Clinical and Operational Overview

Opening Overview

Thoracic medial branch radiofrequency ablation (RFA) is a therapeutic denervation procedure used for chronic thoracic facet-mediated axial pain that has been confirmed through a payer-compliant diagnostic medial branch block pathway. Conventional thermal radiofrequency energy is applied adjacent to the articular nerve branches supplying the selected thoracic zygapophyseal joints to reduce nociceptive transmission.

The procedure occupies a narrower and more complex coverage environment than cervical or lumbar RFA. Medicare LCDs generally include the thoracic region, and eviCore’s current CMM-208 guideline recognizes thoracic RFA when its criteria are met. By contrast, Carelon’s current guideline generally excludes thoracic facet procedures except at the cervicothoracic and thoracolumbar junctions. Evidence is also less mature: ASIPP’s 2020 guideline and a 2023 systematic review characterize thoracic RFA evidence as Level III, with a weak-to-moderate or emerging recommendation.

Coverage and Evidence Snapshot

Evidence at a Glance

Domain	Current Position	Operational Meaning
Traditional Medicare	Criteria-based coverage under MAC-specific facet LCDs; no thoracic-RFA-specific NCD.	Identify the MAC by place of service and apply its active LCD and companion billing article.
Novitas example	Two diagnostic MBBs with at least 80% relief each; repeat RFA requires qualifying pain and functional improvement; one or two levels per session; two RFA sessions per cervical/thoracic region per rolling 12 months.	New Jersey and other Novitas jurisdictions must follow L34892/A56670. Cervical and thoracic RFA share one Medicare region and utilization pool.
Carelon 2026	Thoracic facet injection, MBB, and RFA are listed as not medically necessary except at C7-T1 and T12-L1.	A thoracic RFA request delegated to Carelon may fail regardless of otherwise positive blocks unless the requested joint is one of the stated exceptions or a plan-specific override applies.
eviCore CMM-208	Thoracic RFA may be covered after two sequential diagnostic blocks with at least 80% relief, conservative treatment, and other requirements.	Confirm the exact current plan version and effective date.
Aetna CPB 0016	Nonpulsed RFA may be covered after two positive diagnostic injections with at least 80% relief and other criteria; up to three levels per session.	Aetna’s threshold, level limit, repeat interval, and covered diagnosis list differ from Medicare.
ASIPP 2020	Level III evidence; weak-to-moderate recommendation for thoracic RFA.	Appeals should accurately describe the evidence as limited or emerging, not equivalent to the cervical or lumbar evidence base.
2023 systematic review	Level III evidence for long-term improvement with thoracic radiofrequency neurotomy.	Use as supportive evidence, while acknowledging small studies and methodological limitations.
Overall coverage consensus	No uniform national commercial consensus.	Payer and delegated-reviewer identification is the decisive pre-service control.

Clinical Foundation

Procedure Overview

Thoracic facet joints are paired synovial articulations extending through the thoracic spine. They may contribute to chronic axial mid-back pain and referred pain toward the paraspinal region, posterior chest wall, or rib region. Thoracic RFA does not treat disc herniation, thoracic radiculopathy, myelopathy, spinal cord compression, vertebral fracture, malignancy, infection, or visceral disease.

The procedure is also called thoracic facet radiofrequency denervation, thoracic medial branch neurotomy, thoracic facet rhizotomy, or thoracic zygapophyseal joint neurotomy. The intended service for CPT 64633 and 64634 is conventional thermal denervation performed with fluoroscopic or CT guidance.

Care Pathway

Procedure Expectations

Expectation	Operational Standard
Primary purpose	Reduce pain transmission from thoracic facet joints established as the likely pain generator.
Pathway position	Therapeutic endpoint after the required diagnostic medial branch blocks.
Expected follow-up	Assess pain, function, activity tolerance, medication use, adverse effects, and duration of benefit using the same baseline measures.
Repeat treatment	Potentially appropriate only after the prior RFA met the governing payer threshold and minimum interval.
Prior authorization	Frequently required for commercial plans; hospital outpatient Medicare prior authorization may apply under CMS program rules.
Approval determinants	Payer policy, thoracic coverage posture, diagnostic blocks, exact level/side match, conservative care, exclusion of competing pathology, technique, frequency, and site of service.
Documentation	Must connect the index pain, blocks, levels, laterality, procedure, and outcomes into one auditable chain.

Clinical Foundation

Relevant Anatomy

Thoracic facet innervation is more variable and less completely characterized than cervical or lumbar facet innervation. Traditional descriptions generally attribute articular supply to overlapping thoracic dorsal ramus branches; however, recent anatomic work suggests that the articular branches may arise directly from the dorsal ramus or from different portions of the medial branch, and their relationship to fixed osseous landmarks may vary by level.

Region	Anatomic Consideration	Documentation/Safety Implication
Upper thoracic	Rib, transverse-process, and dorsal ramus relationships differ from the cervical region.	Confirm exact vertebral and facet-joint level in multiple imaging views.
Mid-thoracic	Recent cadaveric evidence describes variable articular-branch courses, sometimes within intertransverse soft tissue.	Avoid overgeneralized claims that one universal landmark or technique applies to every level.
Lower thoracic	Transitional anatomy becomes increasingly relevant toward T11-T12.	Document the joint and articular branches targeted rather than using vague terminology.
T12-L1	Thoracolumbar junction; CMS billing guidance assigns denervation of this joint to CPT 64633/64634.	Do not use lumbar RFA codes solely because one vertebra is lumbar.
Adjacent structures	Pleura and lung, ribs, intercostal neurovascular structures, exiting roots, and spinal cord.	Image guidance, trajectory control, depth awareness, and post-procedure monitoring are essential.

Patient Selection

Clinical Presentation

Thoracic facet-mediated pain is generally predominantly axial and localized to the mid-back or lower thoracic paraspinal region. It may refer around the posterior or lateral chest wall, but the clinical pattern is not sufficiently specific to establish the diagnosis without diagnostic testing.

Pain aggravated by thoracic extension, rotation, lateral bending, sustained posture, or loading.
Paraspinal tenderness near the suspected facet levels.
Restricted thoracic motion or pain with segmental loading.
Pain affecting sleep, sitting tolerance, standing, lifting, work, exercise, or household activity.
Absence of progressive neurologic deficit or a dominant radicular/myelopathic syndrome.
No cardiopulmonary, gastrointestinal, renal, vascular, infectious, oncologic, or fracture-related explanation for the pain.

Patient Selection

Clinical Indications

Thoracic RFA may be considered when the patient has chronic, moderate-to-severe, function-limiting axial thoracic pain; has failed an appropriate course of conservative management; has no more likely untreated pain generator; and has completed the required diagnostic medial branch blocks at the same joints and laterality requested for RFA.

Predominantly axial thoracic pain of the duration required by the payer.
Measurable functional impairment documented with patient-specific activities and, when required, a validated instrument.
Clinical and imaging assessment excluding fracture, tumor, infection, significant deformity, instability, cord pathology, or another dominant condition.
Payer-compliant diagnostic blocks producing the required percentage and duration of pain relief.
Exact correspondence between block levels, laterality, RFA request, authorization, schedule, operative report, and claim.
Conventional thermal technique covered by the governing policy.

Medical Necessity

Patient Selection

Selection Domain	Required Support
Index pain	Predominantly axial thoracic pain; distinguish referred chest-wall pain from radiculopathy and visceral pain.
Duration/severity	Chronic and function limiting at the threshold specified by the payer.
Conservative care	Documented trial, failure, intolerance, or contraindication.
Neurologic assessment	No untreated myelopathy, progressive neurologic deficit, or dominant thoracic radiculopathy.
Imaging/diagnostic assessment	No alternative structural, oncologic, infectious, or fracture-related explanation.
Diagnostic blocks	Required number, same joints and sides, quantified response, expected anesthetic duration.
Coverage posture	The policy must cover the thoracic levels requested; Carelon generally does not except C7-T1 and T12-L1.
Procedure plan	Conventional thermal RFA with fluoroscopy or CT, within level and frequency limits.

Safety

Contraindications and Precautions

Potential Absolute Contraindications

Active systemic or local infection.
Uncorrected clinically significant coagulopathy.
Inability to provide informed consent.
Unstable medical condition.
Anatomic conditions preventing safe image-guided access.
Failure to satisfy the required diagnostic-block pathway.

Relative Contraindications or Planning Issues

Anticoagulant or antiplatelet therapy requiring individualized management.
Implanted pacemaker, defibrillator, neurostimulator, or other electrical device.
Prior thoracic fusion or instrumentation at the requested level.
Pregnancy or inability to use required imaging safely.
Severe anxiety, cognitive impairment, movement disorder, or inability to remain still.
Pulmonary disease or anatomy increasing procedural risk.
Uncertain pain generator or new neurologic findings.

Medical Necessity

Care Pathway and Conservative Treatment

Confirm the clinical problem. Define the index pain and exclude radicular, myelopathic, fracture, infectious, oncologic, cardiopulmonary, and visceral causes.
Document conservative treatment. Record modalities, dates, adherence, outcome, and any contraindication or intolerance.
Verify payer architecture. Identify the payer, product, network, delegated reviewer, site of service, and thoracic coverage posture.
Perform payer-compliant diagnostic blocks. Use the required number of blocks, same joints and sides, permitted injectate, imaging, and timing.
Quantify block response. Capture baseline and post-block pain, percentage relief, duration, anesthetic, and function.
Reconcile levels and laterality. The RFA request must exactly match the qualifying blocks.
Authorize and schedule. Validate codes, units, site, date range, provider, facility, and technique.
Perform and document RFA. Record the actual joints, sides, imaging, thermal method, lesion parameters, and post-procedure status.
Measure outcomes. Track pain, function, duration, and recurrence for repeat-treatment eligibility.

Diagnostic Qualification

Diagnostic Medial Branch Block Predicate

Diagnostic medial branch blocks are the prognostic predicate for thoracic RFA. The block record should identify the facet joints being evaluated, the articular branches targeted, laterality, local anesthetic, image guidance, baseline pain, post-block pain, percentage relief, duration, functional activities, and return of the index pain.

Payer/Reviewer	Typical Diagnostic Requirement	Critical Thoracic Issue
Novitas Medicare example	At least two medically necessary MBBs; each at least 80% relief consistent with the anesthetic.	Thoracic is covered under the same cervical/thoracic region and utilization pool.
eviCore CMM-208	Two sequential diagnostic injections/MBBs at the same levels; at least 80% relief; conservative care and other criteria.	Thoracic levels may be eligible under the current guideline.
Aetna CPB 0016	Two positive diagnostic injections with at least 80% relief for expected anesthetic duration.	Up to three levels may be authorized when criteria are met.
Carelon 2026	Dual blocks are required for covered cervical/lumbar RFN, but thoracic facet procedures are excluded except C7-T1 and T12-L1.	Positive thoracic blocks do not independently overcome the regional exclusion.

Coverage Requirements

Medical Necessity

Initial RFA

Chronic, moderate-to-severe, predominantly axial thoracic pain with measurable functional deficit.
Failure of the payer-required conservative-management period.
No untreated radiculopathy, myelopathy, neurogenic claudication, fracture, tumor, infection, instability, or other more likely cause.
Required diagnostic MBBs at the same joints and laterality, each meeting the applicable response threshold.
Covered thoracic level under the member-specific policy.
Conventional thermal RFA with fluoroscopic or CT guidance.
Compliance with level, session, frequency, and site-of-service limits.

Repeat RFA

Prior RFA date, joints, laterality, technique, and outcome are documented.
Pain and functional benefit meet the active payer threshold and duration.
The same facet-mediated pain has returned without a new dominant cause.
Minimum interval and rolling frequency limits are satisfied.
Repeat blocks are performed only when required by the governing policy or when the pain generator is uncertain.

Clinical Technique

Procedure Technique Overview

Thoracic medial branch RFA is performed under fluoroscopic or CT guidance. The physician identifies the selected thoracic facet-joint level and the articular nerve branches believed to innervate that joint, confirms cannula position in appropriate views, performs stimulation when clinically indicated, administers local anesthetic, and creates a conventional thermal lesion according to the physician’s training, device instructions, anatomy, and institutional protocol.

Pre-procedure confirmation of qualifying blocks, levels, sides, anticoagulation plan, implanted devices, and informed consent.
Sterile preparation and patient positioning appropriate to the requested thoracic levels.
Multiplanar image guidance with attention to pleura, ribs, neural structures, and depth.
Clear documentation of conventional continuous thermal RFA rather than pulsed or another alternative technique.
Post-procedure neurologic and respiratory assessment and discharge instructions.

Safety and Coverage

Sedation and Anesthesia

Routine moderate sedation, monitored anesthesia care, deep sedation, or general anesthesia should not be presumed medically necessary. Under the Novitas LCD, moderate sedation or MAC for RFA may be considered when patient-specific medical necessity is clearly established. Anxiety or patient preference alone is generally insufficient.

Document the condition preventing safe cooperation or immobility.
Describe why local anesthesia alone is inadequate.
Identify the intended level of sedation and monitoring plan.
Reconcile professional and facility authorization requirements.
Avoid routine patterns that may trigger focused review.

Clinical Outcomes

Expected Outcomes

Expected benefit is reduction of confirmed thoracic facet-mediated pain and improvement in function. Relief may be delayed while post-procedural soreness resolves. The procedure does not reverse degenerative changes, and nerves may regenerate over time.

Outcome Domain	Recommended Measurement
Pain	NRS or VAS using the same baseline and follow-up method.
Function	Patient-specific activities, PROMIS, PDQQ-S, or another appropriate functional tool.
Activity	Sitting, standing, sleep, work, lifting, exercise, household tasks, and thoracic motion.
Medication	Change in analgesic use when clinically relevant.
Duration	Onset, maximum benefit, duration, recurrence date, and pattern.
Safety	Neuritis, dysesthesia, weakness, respiratory symptoms, infection, bleeding, or other adverse events.

Safety

Risks and Complications

Potential adverse effects include localized pain, bruising, muscle spasm, transient numbness or dysesthesia, neuritis, vasovagal reaction, medication reaction, bleeding, hematoma, infection, incomplete relief, recurrence, or need for additional treatment.

Thoracic-specific safety concerns include pleural or pulmonary injury, pneumothorax, intercostal or nerve-root injury, unintended neural lesioning, and rare spinal cord injury. Progressive weakness, severe new numbness, loss of coordination, shortness of breath, chest pain, fever, expanding hematoma, or severe escalating pain requires prompt evaluation.

Recovery

Recovery Timeline

Timeframe	Expected Course	Activity/Documentation Checkpoint
Immediately after	Observation, neurologic and respiratory assessment, local soreness possible.	Document vital signs, post-procedure exam, pain, complications, and discharge readiness.
First 24 hours	Soreness or muscle discomfort may be present; follow physician activity and medication instructions.	Driving restrictions apply when sedation was used.
48-72 hours	Temporary post-ablation discomfort or neuritis may persist.	Escalate respiratory symptoms, new weakness, fever, or severe pain.
One week	Early functional change may begin, but full benefit may not yet be evident.	Assess adverse effects and ability to resume normal activity.
Two weeks	Clinical benefit is often more assessable.	Record pain score and patient-specific functional change.
One month	Outcome baseline for continued follow-up.	Document percentage relief, function, medication change, and work/activity status.

Outcome Management

Follow-Up and Repeat Treatment

Follow-up should establish whether the procedure achieved the payer’s repeat-treatment threshold and whether the same facet-mediated pain later recurs. Practices should maintain a regional utilization calendar because Medicare defines cervical and thoracic thermal denervation as one anatomic region for CPT 64633/64634.

Prior procedure date, joints, laterality, and authorized units.
Pain and function before and after RFA.
Duration of clinically meaningful benefit.
Return of the same index pain.
New symptoms or competing diagnoses.
Earliest payer-compliant repeat date and rolling 12-month utilization.

Coding

CPT and HCPCS Coding

Code	Operational Use
64633	Initial cervical or thoracic facet joint treated by neurolytic destruction with fluoroscopic or CT guidance.
+64634	Each additional cervical or thoracic facet joint at a different level during the same session; add-on code used with 64633.
64999	Unlisted nervous-system procedure. Current Medicare article guidance directs nonthermal/pulsed facet denervation to this code and treats it as noncovered under the facet-denervation article.

Report per facet joint, not per nerve, cannula placement, or lesion.
Fluoroscopic or CT guidance is included and should not be unbundled.
The cervical/thoracic code family also applies to the T12-L1 facet joint.
There is no distinct HCPCS Level II code for the RFA procedure; supplies are generally integral to the service or facility payment.

Coding

Modifiers and Units

Scenario	General Reporting Concept	Verification Required
Unilateral right	64633-RT and, when applicable, +64634-RT.	Payer modifier and units.
Unilateral left	64633-LT and, when applicable, +64634-LT.	Payer modifier and units.
Bilateral same joint	Professional Medicare claims generally use modifier 50.	Commercial bilateral methodology may differ.
ASC facility bilateral	Current Novitas guidance directs separate RT and LT lines, one unit each, for the ASC facility; the physician continues modifier 50.	MAC, facility, and payer instructions.
Additional joint	Use +64634 for each additional authorized thoracic joint within the payer’s level limit.	MUE/NCCI, authorization units, and policy limit.

Coding

ICD-10-CM Crosswalk

ICD-10-CM	Description	Operational Caution
M47.814	Spondylosis without myelopathy or radiculopathy, thoracic region.	Common Novitas-supported diagnosis when accurately documented.
M47.815	Spondylosis without myelopathy or radiculopathy, thoracolumbar region.	Use only when the documented region is thoracolumbar.
M47.894	Other spondylosis, thoracic region.	Must accurately describe the condition treated.
M47.895	Other spondylosis, thoracolumbar region.	Verify specificity and payer list.
M48.14	Ankylosing hyperostosis [Forestier], thoracic region.	Use only when clinically diagnosed.
M48.15	Ankylosing hyperostosis [Forestier], thoracolumbar region.	Use only when clinically diagnosed.
M54.6	Pain in thoracic spine.	Aetna lists this symptom code for its RFA policy, but it is not on the primary Novitas RFA covered-code list. Do not assume cross-payer acceptance.

Coding

Coding and Billing Examples

Clinical Scenario	Illustrative Professional Reporting
Right T5-T6 facet RFA	64633-RT
Right T5-T6 and T6-T7 facet RFA	64633-RT and +64634-RT
Bilateral T8-T9 facet RFA	64633-50 when required by the payer
Bilateral T8-T9 and T9-T10 facet RFA	64633-50 and +64634-50 when required by the payer
T12-L1 facet RFA	64633 family, not 64635, under CMS article guidance

These examples are educational. Actual claims must follow current CPT instructions, NCCI edits, MUE logic, the authorization, the operative report, the payer’s bilateral methodology, and professional versus facility billing requirements.

Medicare

CMS National Guidance

CMS has no National Coverage Determination dedicated specifically to thoracic facet RFA. Traditional Medicare coverage is principally governed by the reasonable-and-necessary standard, the applicable MAC LCD, the companion billing and coding article, NCCI edits, payment-system rules, and any applicable hospital outpatient prior authorization requirements.

The Medicare Coverage Database should be searched by the place of service and the current document ID before every policy-sensitive submission.

Medicare

Medicare National Coverage Determinations

National Document	Relevance
No thoracic facet RFA NCD	There is no single national thoracic-RFA coverage rule replacing the MAC LCD.
NCD 220.1 - Computed Tomography	May be referenced in local coverage policy for CT use; it does not independently establish facet RFA coverage.
NCD 150.7 - Prolotherapy, Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents	Relevant to excluded sclerosing approaches; it does not authorize thermal facet RFA.
NCD 30.3 - Acupuncture	Sometimes listed as a related national document; not the basis for thoracic RFA coverage.

Medicare

Medicare LCDs and Billing Articles

Novitas L34892 is the governing LCD for New Jersey and other Novitas jurisdictions. It covers thermal RFA of cervical, thoracic, or lumbar paravertebral facet nerves when criteria are met. Companion Article A56670 provides the coding, bilateral, T12-L1, nonthermal, diagnosis, and utilization instructions.

Medicare Requirement - Novitas Example	Current Standard
Initial RFA	At least two medically necessary diagnostic MBBs, each producing at least 80% sustained relief consistent with the anesthetic.
Repeat RFA	At least 50% pain improvement for at least 6 months and at least 50% functional/ADL improvement, using the same scale.
Frequency	No more than two RFA sessions per covered cervical/thoracic region per rolling 12 months.
Levels	One or two levels, unilateral or bilateral, per session per region; three or four levels are noncovered under the LCD.
Imaging	Fluoroscopy or CT required.
Technique	Conventional thermal; nonthermal/pulsed methods are not reported with 64633/64634.
Sedation	Patient-specific moderate sedation/MAC may be considered when clearly necessary; routine use is not supported.

Medicare

MAC-Specific Requirements

MAC/Contractor	Current Core Document(s)	Operational Note
Novitas Solutions	L34892 / A56670	Includes New Jersey; verify current version and proposed-policy status.
First Coast Service Options	L33930 / A57787	Florida, Puerto Rico, and U.S. Virgin Islands.
Wellpoint Federal / former NGS	L35936 / A57826	Contractor field changed in 2026; policy documents remain active.
Noridian	L38801 / A58403	Jurisdictions E and F consolidated under one LCD effective April 16, 2026; retired L38803 should not be cited as current.
WPS	L38841 / current companion article	Verify the current article version in MCD.
Palmetto GBA	L38765 / A58350	Verify current version and jurisdiction.
CGS Administrators	L38773 / A58364	Current article updated in 2026.

Commercial Coverage

Commercial Payer Policies

Payer	Current Public Position	Thoracic Operational Interpretation
Aetna	Covers nonpulsed facet denervation when detailed criteria are met; two positive blocks with at least 80% relief; up to three levels; repeat interval and outcome requirements apply.	Thoracic RFA can be covered under CPB 0016, subject to plan and precertification.
UnitedHealthcare	Public 2026 ablative-treatment policy addresses alternative/unlisted spinal ablation and defines/excludes several techniques; conventional 64633/64634 selection criteria may be applied through proprietary criteria or plan terms.	Do not assign a public UHC block threshold without the member-specific review pathway.
Cigna	May use eviCore CMM-208 for selected products; current and future effective versions are published.	Verify whether eviCore, another vendor, or a Cigna policy controls the request.
Humana, Molina, WellCare, regional plans	Plan, state, product, and delegation specific.	Retrieve the live member-specific policy; do not extrapolate from Medicare or another payer.

Commercial Coverage

Blue Cross Blue Shield Policies

Blue Cross Blue Shield plans are independent and cannot be summarized as one national policy. The relevant variables include the home plan, BlueCard arrangement, employer funding, line of business, state mandate, Medicare Advantage status, and delegated utilization-management vendor.

When Carelon is delegated, thoracic RFA may be excluded except at C7-T1 and T12-L1 under the current Carelon guideline.
When eviCore is delegated, thoracic RFA may be considered under CMM-208 if all criteria are met.
Federal Employee Program, Medicaid, Medicare Advantage, and self-funded employer plans may use different criteria.
Confirm whether the home plan or host plan controls authorization and payment.

Delegated Review

Delegated Utilization-Management Criteria

Delegated Reviewer	Thoracic RFA Position	Operational Action
Carelon	Current 2026 guideline lists thoracic facet injection, MBB, and RFA as not medically necessary except C7-T1 and T12-L1.	Identify this exclusion before blocks are scheduled; determine whether a plan-specific policy supersedes Carelon or whether an exception pathway exists.
eviCore	CMM-208 recognizes cervical, thoracic, and lumbar facet RFA after two qualifying diagnostic procedures and other criteria.	Use the version effective for the requested date of service; confirm level, block, fusion, interval, and frequency rules.
Cohere Health	Criteria are plan and portal specific; no single public standard should be applied to all members.	Review the pathway displayed for the exact member and payer.
Evolent / RadMD	Plan-specific authorization and clinical criteria.	Use the health-plan-specific RadMD or Evolent resource and save the applicable criteria/version.

Evidence

Clinical and Specialty-Society Guidelines

Organization / Source	Thoracic RFA Position
ASIPP comprehensive facet guidelines (2020)	Thoracic RFA: Level III evidence with weak-to-moderate recommendation.
Pain Physician systematic review/meta-analysis (2023)	Level III evidence for thoracic radiofrequency neurotomy for long-term improvement; Level II for therapeutic thoracic MBB.
International Pain and Spine Intervention Society	Current public practice resources should be reviewed; a 2025 thoracic cohort noted that formal IPSIS guidelines do not describe a thoracic RFA technique.
Recent anatomic studies	Question the assumption of a uniform thoracic medial-branch course and support level-specific anatomic caution.

Evidence

Evidence Interpretation

The thoracic evidence base is materially thinner than the cervical and lumbar evidence base. The 2023 systematic review identified limited studies and assigned Level III evidence to thoracic radiofrequency neurotomy. A 2025 retrospective cohort of 18 patients reported that approximately 56% achieved at least 50% pain reduction at three months; successful responders with symptom recurrence reported an average of approximately 70% relief lasting about nine months. The study was small, retrospective, and uncontrolled.

Evidence should be presented accurately in authorizations and appeals. Do not claim Level I or Level II evidence for thoracic RFA, and do not represent one small cohort as definitive. The strongest argument is a carefully selected individual patient with controlled diagnostic confirmation, no better pain generator, a covered policy pathway, and transparent acknowledgment of the evidence limitations.

Revenue Cycle

Reimbursement and Revenue Integrity

Reimbursement depends on calendar year, locality, site of service, bilateral processing, units, payer contract, authorization, diagnosis, and claim accuracy. Practices should use the current Medicare Physician Fee Schedule, ASC payment files, hospital outpatient payment resources, and commercial contract terms rather than publishing a static national dollar amount.

Confirm professional and facility authorization separately when required.
Reconcile the authorization with CPT 64633/+64634, laterality, units, provider, facility, and date range.
Do not unbundle image guidance or integral supplies.
Validate that the diagnosis is on the payer’s current covered list.
Monitor denial reason codes, underpayments, and post-payment medical-record requests.

Prior Authorization

Prior Authorization Requirements

Authorization Element	Required Verification
Payer architecture	Payer, product, employer group, state, network, line of business, and delegated reviewer.
Thoracic coverage	Whether the requested thoracic joint is covered, excluded, or junction-only.
Clinical criteria	Pain duration, severity, function, conservative care, examination, imaging, and exclusion of competing pathology.
Diagnostic pathway	Number of blocks, levels, sides, injectate, timing, pain relief, duration, and function.
Procedure request	CPT codes, units, laterality, exact joints, conventional thermal technique, site of service, and date range.
Repeat request	Prior RFA date, benefit, duration, interval, and rolling utilization.
Sedation	Separate authorization and patient-specific medical necessity when applicable.

Prior Authorization

Prior Authorization Workflow

Verify benefits and delegation. Determine who actually reviews interventional pain services.
Retrieve the current policy. Save the version and effective date applicable to the planned date of service.
Screen thoracic eligibility before blocks. Identify Carelon’s regional exclusion or other plan limitations early.
Assemble the clinical record. Current note, imaging, conservative care, block reports, outcome notes, prior RFA records, and order.
Perform level-and-laterality reconciliation. Compare every document and requested unit.
Submit a concise policy-mapped narrative. Answer each criterion directly and index the supporting records.
Track the case. Follow portal, fax, and telephone status; document reference numbers and deadlines.
Validate the determination. Confirm provider, facility, codes, units, levels, sides, and dates before scheduling.
Reconcile at claim scrub. Ensure the operative report and claim match the approval and actual service.

Documentation

Clinical Documentation Requirements

Pre-Procedure

Index thoracic pain, duration, severity, and specific functional impairment.
Focused thoracic and neurologic examination.
Imaging and differential diagnosis, including exclusion of visceral, fracture, tumor, infection, and cord pathology.
Conservative treatment with dates, outcome, intolerance, or contraindication.
Two qualifying block reports and outcome notes when required.
Exact facet joints and laterality requested.
Policy and authorization verification.
Anticoagulation, implanted-device, pulmonary, and sedation planning.

Procedure Note

Time-out, patient position, imaging modality, exact joints, laterality, and articular branches targeted.
Cannula and lesion method, conventional thermal technique, temperature/duration as performed, stimulation when used, and local anesthetic.
Complications, post-procedure neurologic and respiratory status, and discharge instructions.

Follow-Up

Pain and functional change using the same baseline measures.
Duration of benefit, medication change, activity, work, and adverse effects.
Recurrence pattern and repeat-treatment eligibility.

Documentation

Clinical Documentation Checklist

☐ Payer, product, line of business, and delegated reviewer confirmed.

☐ Current thoracic coverage policy saved.

☐ Requested level is covered; Carelon exception issue addressed.

☐ Chronic axial thoracic pain and functional impairment documented.

☐ Conservative treatment documented.

☐ Competing pathology excluded.

☐ Required diagnostic MBBs completed.

☐ Baseline and post-block pain scores documented.

☐ Relief percentage and duration documented.

☐ Functional activity response documented.

☐ Block joints and laterality match RFA request.

☐ Conventional thermal technique planned.

☐ Fluoroscopy or CT planned.

☐ Level and frequency limits verified.

☐ Prior RFA outcomes documented for repeat request.

☐ Sedation medical necessity documented when requested.

☐ Authorization codes, units, provider, facility, and dates validated.

☐ Professional and facility claim methodology reconciled.

☐ Post-procedure outcome plan established.

Documentation

Documentation Pearls

Strong Documentation

Name the facet joint, not only the nerve or transverse process.
Use the same index-pain description across both blocks and the RFA request.
Calculate relief from actual scores.
Document function during the anesthetic window.
Distinguish axial thoracic pain from radiculopathy and visceral pain.
Capture the governing policy and thoracic coverage posture.

Weak Documentation

“Thoracic pain” without diagnosis or differential.
“Positive blocks” without scores, duration, or function.
“Multiple thoracic levels” without exact joints and sides.
Imaging degeneration presented as proof of the pain generator.
No explanation of why the procedure is covered under the member’s reviewer.
No prior outcome data for a repeat request.

Payer Strategy

Payer Perspective

A payer reviewer is not deciding whether thoracic RFA exists as a procedure. The reviewer is deciding whether this member’s plan covers thoracic RFA, whether the requested joints are eligible, whether the diagnostic pathway satisfies the active criteria, whether another condition better explains the pain, and whether the requested technique, levels, frequency, and site of service are covered.

For thoracic RFA, the first question is often policy jurisdiction rather than clinical detail: Carelon, eviCore, Aetna, Medicare, and a local BCBS plan can reach different determinations on the same clinical record.

Clinical Practice

Clinical Pearls

Thoracic facet pain is a diagnosis of controlled clinical correlation, not an imaging diagnosis.
Chest-wall referral should trigger a careful radicular and visceral differential.
Recent anatomy literature supports caution about assuming one universal medial-branch target at every thoracic level.
T12-L1 is coded with the cervical/thoracic RFA family.
New neurologic or respiratory symptoms require reassessment, not automatic repetition of the facet pathway.

Safety Pearls

Review pleural and rib relationships before access.
Use multiple imaging views and document them.
Plan implanted-device management in accordance with manufacturer instructions.
Document post-procedure respiratory status.
Do not allow deep sedation to eliminate meaningful patient feedback without a compelling medical reason.

Denial Prevention

Top Five Prior Authorization and Billing Denials

Ranked Denial	Why It Occurs	Prevention	Appeal Strategy
1. Thoracic region excluded by the delegated reviewer	Carelon generally excludes thoracic facet procedures except C7-T1 and T12-L1.	Identify delegation and regional eligibility before diagnostic blocks.	Confirm whether a plan-specific policy supersedes Carelon; request exception review only with a truthful evidence-based rationale.
2. RFA levels do not match qualifying blocks	Order, reports, authorization, or claim describe different joints or sides.	Use a level-and-laterality reconciliation form.	Submit the complete block chain and corrected clinical order.
3. Block response is incomplete	The note lacks scores, percentage, duration, anesthetic, or function.	Use a structured block-outcome template.	Provide contemporaneous calculations and functional evidence; do not invent missing data.
4. Evidence or diagnosis is overstated	The appeal claims stronger evidence than exists or uses thoracic pain alone as proof.	Describe Level III evidence accurately and document the facet diagnosis.	Pair the evidence with individualized diagnostic confirmation and policy criteria.
5. Level/frequency/technique violation	Too many levels, shared cervical/thoracic frequency exceeded, repeat too early, or noncovered technique.	Use a regional utilization calendar and technique-specific authorization.	Appeal only if the record and active policy support an error in the determination.

Denial Prevention

Create a payer-delegation hard stop before thoracic diagnostic blocks are scheduled.
Build a Carelon/eviCore/Aetna/Medicare thoracic coverage matrix rather than a generic RFA policy summary.
Attach both block reports and outcome notes to every initial RFA request.
Maintain one cervical/thoracic Medicare RFA utilization calendar.
Use structured fields for joint, laterality, technique, temperature, imaging, and outcome.
Scrub the professional and facility claims against the authorization and operative report.
Audit thoracic RFA denials by root cause: regional exclusion, block insufficiency, level mismatch, diagnosis, frequency, technique, or site of service.

Appeals

Appeals and Reconsideration

A thoracic RFA appeal should begin with the exact denial rationale and the governing policy. An appeal cannot cure a clear plan exclusion merely by adding more clinical records. When the denial reflects missing or misread criteria, organize the appeal around the policy’s elements.

Identify the member, service, codes, joints, sides, denial date, and reference number.
Quote or accurately summarize the controlling policy and effective version.
Address whether thoracic RFA is covered under the plan or delegated reviewer.
Present the diagnostic blocks in a table with scores, relief, duration, anesthetic, and function.
Explain the differential diagnosis and exclusion of competing pathology.
Describe the conventional thermal technique and requested level count.
Attach indexed records and request the appropriate reconsideration, peer-to-peer, external review, or exception process.

Appeals

Peer-to-Peer Preparation

Preparation Item	Physician Should Have Immediately Available
Coverage architecture	Payer, product, delegated reviewer, policy title, version, and thoracic inclusion/exclusion.
Clinical indication	Index pain, duration, function, conservative care, examination, imaging, and differential.
Diagnostic blocks	Dates, joints, sides, scores, relief percentage, duration, anesthetic, and function.
Procedure request	CPT 64633/+64634, exact joints, laterality, conventional thermal technique, imaging, facility.
Evidence	ASIPP Level III and 2023 systematic review, accurately characterized.
Requested action	Approval under criteria, correction of a factual error, or plan-specific exception review.

Opening statement: “This request is for conventional thermal thoracic medial branch RFA at [joints and sides]. The patient has chronic function-limiting axial thoracic pain, no more likely untreated pain generator, and two diagnostic blocks at the same joints producing [results]. We have confirmed that [policy/reviewer] governs the request, and we are asking for [criteria-based approval or specific exception review].”

GoHealthcare

GoHealthcare Perspective

Thoracic RFA is a payer-intelligence procedure as much as a documentation procedure. A clinically appropriate patient can be approved under one delegated pathway and categorically excluded under another. The operational failure occurs when the practice discovers that difference only after performing two diagnostic blocks.

GoHealthcare’s standard is to verify the reviewer and regional policy before the diagnostic sequence begins, preserve the evidence chain through authorization and billing, and measure outcomes from the first procedure forward. That protects patient access while avoiding unnecessary blocks, avoidable denials, and unsupported appeals.

GoHealthcare

GoHealthcare Clinical Insights

Pre-Service Intelligence

Determine whether the member is under Medicare, Aetna, eviCore, Carelon, Cohere, Evolent, or a plan-specific policy before the first block.

Evidence Chain

Carry joint, side, pain scores, relief percentage, duration, and function from both blocks into the RFA packet and claim.

Outcome Governance

Track pain and function with the same methods so repeat eligibility can be demonstrated without reconstructing the record months later.

GoHealthcare

GoHealthcare Leadership Perspective

Thoracic medial branch RFA illustrates a central leadership principle in healthcare operations: clinical capability does not create uniform coverage. Leaders must build systems that recognize policy variation before it becomes patient friction or financial loss.

A mature practice does not ask only, “Does this patient meet RFA criteria?” It asks, “Which entity is making the determination, does that entity recognize thoracic RFA, what evidence standard applies, and can the clinical and billing record remain consistent from the first diagnostic block through follow-up?”

Responsible AI can assist by identifying the delegated reviewer, detecting regional exclusions, reconciling levels, calculating block response, monitoring frequency, and comparing the scheduled service with the authorization. Human clinical and compliance oversight remains essential because the most consequential thoracic decision may be whether the requested pathway is covered at all.

GoHealthcare

GoHealthcare Case Study

The following fictional educational case study does not identify an actual patient, physician, practice, or client.

Clinical Scenario

A 61-year-old operations executive had 18 months of right mid-thoracic axial pain aggravated by rotation, prolonged sitting, and lifting. MRI showed thoracic facet arthropathy without fracture, tumor, infection, cord compression, or a concordant disc herniation. Cardiopulmonary and visceral causes had been evaluated. Physical therapy, home exercise, activity modification, and nonopioid medications had failed.

Documentation Challenge

Two right T6-T7 and T7-T8 diagnostic MBBs produced 85% and 90% relief, but the outcome notes did not specify the functional activities completed during the anesthetic window.

Authorization Challenge

The practice initially believed the plan used eviCore criteria. Benefit verification later showed that Carelon was the delegated reviewer. The current Carelon guideline excluded thoracic facet RFA at these levels.

Resolution

The team stopped the routine authorization pathway, informed the physician and patient of the coverage exclusion, and requested plan-specific exception review rather than mischaracterizing the service. The physician documented the diagnostic certainty, the lack of alternatives addressing the confirmed facet pain, the accurate Level III evidence, the functional response to both blocks, and the reason the case warranted medical-director review.

Outcome

In this fictional scenario, the health plan granted a one-time exception after peer-to-peer review. The authorization specified the exact joints, side, conventional thermal technique, provider, facility, units, and date range. Follow-up documented 70% pain reduction and meaningful improvement in sitting and work tolerance for eight months.

Lessons Learned

Delegated-reviewer verification should occur before diagnostic blocks, not after them.
A categorical guideline exclusion requires a plan-specific exception strategy, not a larger routine packet.
Accurate evidence characterization improves physician-review credibility.
Functional response should be documented after the blocks and the RFA.
Exception approval is case specific and should never be presented as a general coverage precedent.

Operations

Operational Excellence by Role

Role	Thoracic RFA Responsibilities
Physicians	Define the index pain and differential; select joints; document block and RFA rationale; discuss evidence limitations and alternatives.
APPs	Maintain continuity across conservative care, blocks, authorization, procedure, and follow-up.
Prior Authorization Teams	Identify delegated reviewer; screen thoracic coverage; reconcile levels; submit policy-mapped records; track deadlines.
Clinical Staff	Collect standardized pain/function measures; document block activities; support anticoagulation, device, sedation, and post-procedure workflows.
Coding Teams	Report per joint; apply correct code family, modifiers, units, diagnosis, and T12-L1 rule.
Revenue Cycle Teams	Reconcile authorization, operative report, professional/facility claims, denials, and underpayments.
Practice Administrators	Maintain payer matrix, regional utilization calendar, templates, audits, and KPIs.
ASC Teams	Validate facility authorization, bilateral claim methodology, equipment, sedation support, and complete records.
AI Governance Leaders	Approve data sources, human-review rules, audit trails, exception handling, and model monitoring.

Operations

GoHealthcare Best Practices

Verify thoracic coverage before the first diagnostic block.
Maintain separate payer logic for Medicare, Carelon, eviCore, Aetna, BCBS, Cohere, Evolent, and other plan-specific pathways.
Use one standardized diagnostic-block outcome form.
Name facet joints and laterality consistently across all records.
Use a cervical/thoracic regional frequency calendar for Medicare.
Capture conventional thermal technique in a required structured field.
Measure baseline and follow-up pain and function using the same methods.
Create denial templates by root cause rather than one generic RFA appeal.
Audit thoracic RFA cases for payer eligibility, block linkage, coding, and outcome completeness.

GoHealthcare Frameworks

GoHealthcare Framework Applied

GoHealthcare Framework™	Application to Thoracic RFA
Patient Access Excellence Framework™	Early coverage screening prevents patients from completing blocks for a service the delegated reviewer excludes.
Prior Authorization Excellence Framework™	Policy-specific qualification, level reconciliation, submission, tracking, and determination validation.
Clinical Documentation, Coding & Revenue Integrity Framework™	Joint-based anatomy and coding, block evidence, technique capture, modifier/units accuracy, and claim reconciliation.
Regulatory, Risk & Compliance Excellence Framework™	Medical necessity, policy version control, audit readiness, sedation, device planning, and evidence integrity.
AI Governance & Digital Transformation Excellence Framework™	Human-governed automation for delegation detection, regional exclusions, block calculations, frequency, and claim matching.
Quality, Performance & Continuous Improvement Framework™	Track approval rates, denial causes, block-to-RFA conversion, outcomes, duration, and adverse events.

Quality

Common Mistakes and How to Avoid Them

Team	Common Mistake	Corrective Control
Physician	Treating thoracic RFA as equivalent to lumbar RFA in evidence and coverage.	Document the thoracic-specific evidence and payer pathway.
Clinical staff	Recording “80% relief” without scores, duration, and function.	Use a mandatory outcome template.
Prior authorization	Missing Carelon’s thoracic exclusion.	Verify delegation and the exact regional policy before blocks.
Coding	Billing by nerve or using lumbar codes for T12-L1.	Code by joint; use 64633/64634 for T12-L1.
Revenue cycle	Ignoring the shared cervical/thoracic Medicare frequency pool.	Use a regional utilization calendar.
Administrator	Using one generic RFA policy matrix.	Maintain payer- and reviewer-specific thoracic logic.
Appeals team	Claiming Level I or II thoracic evidence.	Use accurate Level III evidence and individualized diagnostic support.

Quality

Pearls and Pitfalls

Pearls

Confirm reviewer before blocks.
Name joints and sides, not vague “thoracic levels.”
Quantify block response and function.
Treat evidence transparency as an appeal strength.
Track cervical and thoracic Medicare RFA together.

Pitfalls

Carelon regional exclusion discovered after blocks.
Thoracic pain coded without a supported facet diagnosis.
Overconfident anatomic claims despite variable articular branches.
Nonthermal technique billed as conventional thermal RFA.
Too many levels or repeat treatment before the required interval.

Clinical and Operational Comparison

Procedure Comparison

Feature	Thoracic Medial Branch RFA	Thoracic MBB	Cervical RFA	Lumbar RFA
Role	Therapeutic denervation	Diagnostic/prognostic test	Therapeutic denervation	Therapeutic denervation
CPT family	64633 / +64634	64490 / +64491 / +64492	64633 / +64634	64635 / +64636
Evidence	Level III; weak-to-moderate/emerging	Level II therapeutic MBB evidence in 2023 review; diagnostic role policy specific	Stronger Level II evidence	Level II evidence
Coverage fault line	Carelon generally excludes except C7-T1/T12-L1; eviCore/Medicare may cover	Same Carelon exclusion problem for most thoracic levels	Broad criteria-based coverage	Broad criteria-based coverage
Anatomic issue	Variable articular-branch course; pleural proximity	Same diagnostic targeting challenge	Vertebral artery, roots, cord, TON	Typical lumbar medial branch/dorsal ramus targets
Medicare region	Shares cervical/thoracic region and frequency pool	Cervical/thoracic diagnostic region	Shares thoracic pool	Separate lumbar/sacral pool
Major operational risk	Wrong reviewer or categorical regional exclusion	Performing blocks without downstream RFA coverage	Level mismatch and safety documentation	High-volume frequency, level, and coding errors

Executive Summary

GoHealthcare Scorecard

Category	Assessment
Documentation Complexity	High
Prior Authorization Complexity	Very High
Payer Variation	Very High
Denial Risk	High
Appeal Opportunity	Case specific
Clinical Documentation Burden	High
Coding Complexity	Moderate
ASC Appropriate	Generally, when covered and clinically appropriate
Medicare Covered	Yes, criteria based
Commercial Coverage	Highly variable
Evidence Strength	Limited / Level III
AI Opportunity	High
Human Governance Requirement	Essential

Frequently Asked Questions

What is thoracic medial branch RFA?

A conventional thermal denervation procedure intended to reduce pain transmission from thoracic facet joints confirmed as the likely pain generator.

Is thoracic RFA the same as an epidural injection?

No. RFA treats facet-joint articular nerve branches for axial pain. Epidural injections address selected radicular or epidural inflammatory conditions.

Does Medicare cover thoracic RFA?

Traditional Medicare MAC LCDs generally include thoracic RFA when all criteria are met. The active MAC policy for the place of service controls.

Is there a national Medicare NCD?

No dedicated national thoracic facet RFA NCD exists. Coverage is primarily local through MAC LCDs and companion articles.

How many diagnostic blocks does Medicare require?

The current Novitas example requires at least two medically necessary MBBs, each producing at least 80% relief consistent with the anesthetic.

Does Carelon cover thoracic RFA?

Carelon’s current 2026 guideline generally lists thoracic facet injection, MBB, and RFA as not medically necessary except at C7-T1 and T12-L1. Plan-specific overrides must be verified.

Does eviCore cover thoracic RFA?

The current CMM-208 pathway can recognize thoracic RFA after qualifying diagnostic procedures and other criteria, subject to the exact plan version.

What evidence supports thoracic RFA?

ASIPP 2020 and a 2023 systematic review characterize the evidence as Level III. A small 2025 cohort reported improvement in roughly 56% of patients at three months.

Can imaging alone diagnose thoracic facet pain?

No. Degenerative findings are common and do not independently identify the pain generator. Clinical correlation and diagnostic blocks are central.

What CPT codes apply?

64633 for the initial cervical/thoracic facet joint and +64634 for each additional joint within policy limits.

How is T12-L1 coded?

CMS billing guidance assigns denervation of the T12-L1 facet joint to the cervical/thoracic code family, beginning with 64633.

Is the procedure coded per nerve?

No. It is reported per facet joint, regardless of the number of nerve branches or lesions.

Can thoracic RFA be bilateral?

Potentially, when medically necessary and permitted. Modifier, units, authorization, and facility reporting must be verified.

How many levels can be treated?

Novitas Medicare generally allows one or two levels per session; Aetna and eviCore may allow up to three under their policies. Carelon generally excludes thoracic levels except the stated junctions.

How often may RFA be repeated?

The payer controls. Novitas generally limits two sessions per cervical/thoracic region per rolling 12 months and requires qualifying prior benefit.

Do cervical and thoracic RFA share a Medicare frequency pool?

Yes. CMS article guidance defines one cervical/thoracic region for 64633/64634.

Is pulsed RFA covered under 64633/64634?

No under current Medicare article guidance. Pulsed or other nonthermal facet denervation is directed to 64999 and is noncovered under that article.

Is cooled RFA automatically covered?

No. Coverage is payer and policy specific; several commercial payers consider cooled facet RFA unproven or excluded.

Can sedation be used?

Patient-specific moderate sedation or MAC may be considered for RFA when medically necessary, but routine use or anxiety alone is generally insufficient.

What are the most common denial causes?

Thoracic regional exclusion, missing or inconsistent blocks, level/side mismatch, insufficient diagnosis or differential, frequency/level violations, and technique mismatch.

What should be tracked after RFA?

Pain, function, activity, medication change, adverse effects, duration of benefit, recurrence, and repeat eligibility.

Why is thoracic anatomy operationally important?

Recent studies describe variable articular-branch courses, so documentation should avoid vague or overgeneralized anatomy and should clearly identify the joint and image-guided targets.

Executive Summary

Key Takeaways

Thoracic RFA is a therapeutic procedure for diagnostically confirmed facet-mediated axial pain, not a general treatment for thoracic pain.
Coverage varies more sharply than for cervical or lumbar RFA.
Carelon generally excludes thoracic facet procedures except C7-T1 and T12-L1; eviCore, Aetna, and Medicare may cover under criteria.
Medicare requires the active MAC LCD and article; cervical and thoracic thermal RFA share one utilization region.
Code 64633/+64634 per facet joint, including T12-L1; image guidance is bundled.
The thoracic evidence base is Level III and should be characterized accurately.
Recent anatomy literature supports caution about universal target assumptions.
The strongest operational control is payer/delegation screening before diagnostic blocks.
Every RFA request must preserve the block-to-ablation level, side, outcome, and technique chain.
Outcome tracking is required for repeat treatment, compliance, and quality improvement.

Innovation

Future Outlook

Thoracic RFA policy is likely to remain heterogeneous until the evidence base expands. Future prospective trials, registries, and comparative studies may clarify patient selection, optimal diagnostic-block paradigms, lesion technology, and duration of benefit. Recent anatomic research may also refine the terminology and targets used for thoracic facet denervation.

AI-assisted workflow tools can add value by detecting delegated reviewers, identifying thoracic exclusions, reconciling block levels and sides, calculating relief, monitoring the shared cervical/thoracic Medicare frequency pool, and matching authorizations with claims. These tools require human clinical review, policy version control, audit trails, and governance for exceptions.

New technologies, including multi-tined or cooled systems, should not be assumed reimbursable under conventional RFA coverage. Evidence, coding, and payer policy must be evaluated separately.

Design

Visual Recommendations

Thoracic facet and dorsal ramus/articular-branch anatomy illustration with upper, mid, lower, and junctional distinctions.
Payer decision tree: Medicare/eviCore/Aetna versus Carelon thoracic exclusion.
Diagnostic-block-to-RFA workflow.
Cervical/thoracic Medicare utilization calendar graphic.
T12-L1 coding decision aid.
Thermal versus pulsed/cooled/alternative-technique matrix.
Level-and-laterality reconciliation worksheet.
Top-five-denials process map.
Recovery and outcome timeline.
AI-governed pre-service validation architecture.

Resources

Recommended GoHealthcare Downloads

Thoracic RFA Documentation Checklist.
Thoracic Diagnostic MBB Verification Worksheet.
Carelon Thoracic Coverage Screening Tool.
eviCore CMM-208 Criteria Checklist.
Medicare Cervical/Thoracic RFA Utilization Calendar.
T12-L1 Coding Quick Reference.
Thoracic RFA Prior Authorization Checklist.
Peer-to-Peer Preparation Form.
Thoracic RFA Appeal Checklist.
Professional and ASC Claim Reconciliation Checklist.
Post-RFA Outcome Assessment.
AI-Assisted Policy and Level Validation Governance Checklist.

Resources

Reading Recommendations

Active MAC LCD and article. Read the coverage criteria, level limits, frequency, sedation, diagnosis, and coding sections together.
Member-specific commercial or delegated policy. Confirm whether thoracic RFA is recognized before diagnostic blocks.
Carelon 2026 Interventional Pain Management guideline. Review the explicit thoracic exclusion and junction exceptions.
eviCore CMM-208. Review the version applicable to the date of service.
Aetna CPB 0016. Review nonpulsed RFA criteria, levels, repeat treatment, and covered codes.
ASIPP 2020 facet guideline and 2023 thoracic systematic review. Understand the Level III evidence position.
2024 thoracic articular-branch anatomy study and 2025 outcome cohort. Review the evolving anatomic and clinical evidence.
Current CPT, NCCI, MUE, MPFS, ASC, and OPPS resources. Keep coding, coverage, and payment determinations separate.

Request Help

GoHealthcare Practice Solutions supports musculoskeletal specialty practices with prior authorization, utilization management, clinical documentation, coding, revenue integrity, payer strategy, appeals, and operational transformation.

Request Help

Developed by: Pinky Maniri, MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare A.I. Governance
Founder and Chief Executive Officer, GoHealthcare Practice Solutions
Connect on LinkedIn

Thoracic Medial Branch Radiofrequency Ablation

Potential Absolute Contraindications

Relative Contraindications or Planning Issues

Initial RFA

Repeat RFA

Pre-Procedure

Procedure Note

Follow-Up

Strong Documentation

Weak Documentation

Clinical Pearls

Safety Pearls

Pre-Service Intelligence

Evidence Chain

Outcome Governance

Clinical Scenario

Documentation Challenge

Authorization Challenge

Resolution

Outcome

Lessons Learned

Pearls

Pitfalls

Related Procedures

Operational Resources

AI and Governance

Centers for Medicare & Medicaid Services

Commercial Payers and Delegated Reviewers

Clinical Guidelines and Evidence

GoHealthcare Practice Solutions

Request Help

DISCLAIMER PRIVACY POLICY TERMS OF USE CONTACT US

Search GoHealthcare Practice Solutions